[On the prophylactic treatment of cyclothymic diseases with a carboanhydrase inhibitor (author's transl)].
D000086:Acetazolamide / Q000627:therapeutic use*; D000639:Amitriptyline / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000150:complications; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy; D010554:Personality Disorders / Q000150:complications / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use; D013997:Time Factors
D002257:Carbonic Anhydrase Inhibitors; D000639:Amitriptyline; D006220:Haloperidol; D000086:Acetazolamide; D011188:Potassium
Zur prophylaktischen Behandlung zyklothymer Erkrankungen mit einem CarboanhyPDRASEHEMMER